Cargando…
Eosinophilic granulomatosis with polyangiitis after treatment with dupilumab
Eosinophilic granulomatosis with polyangiitis (EGPA) in association with the use of asthma medications has been reported. We report the first Asian case of EGPA developed after dupilumab administration in a 77-year-old Japanese woman and discuss the association between dupilumab and EGPA.
Autores principales: | Yamazaki, Kai, Nomizo, Takafumi, Hatanaka, Kazuhito, Hayama, Naoki, Oguma, Tsuyoshi, Asano, Koichiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509859/ https://www.ncbi.nlm.nih.gov/pubmed/37781267 http://dx.doi.org/10.1016/j.jacig.2022.03.006 |
Ejemplares similares
-
Dupilumab-Associated Eosinophilic Granulomatosis With Polyangiitis
por: Persaud, Purnadeo, et al.
Publicado: (2022) -
Rituximab and dupilumab improve eosinophilic granulomatosis with polyangiitis with multiple pulmonary thrombi
por: Adachi, Sei, et al.
Publicado: (2022) -
Severe Asthma Where Eosinophilic Granulomatosis with Polyangiitis Became Apparent after the Discontinuation of Dupilumab
por: Ikeda, Miki, et al.
Publicado: (2021) -
Eosinophilic Granulomatosis with Polyangiitis
por: Shukla, Ratnakar, et al.
Publicado: (2022) -
Eosinophilic granulomatosis with polyangiitis developed after dupilumab administration in patients with eosinophilic chronic rhinosinusitis and asthma: a case report
por: Suzaki, Isao, et al.
Publicado: (2023)